184 results on '"Francés A"'
Search Results
2. WED-113 Histological, molecular, and neuromotor alterations of the liverbrain axis in an aged model of experimental cirrhosis
3. Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH
4. FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis
5. Mutational landscape of a chemically-induced mouse model of liver cancer
6. Study of epigenetic control of LSECtin in hepatic antigen presenting cells during experimental cirrhosis
7. Bacterial translocation has an early onset in cirrhosis and induces a selective inflammatory response
8. Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices
9. Bifidobacterium pseudocatenulatum CECT7765 induces an M2 anti-inflammatory transition in macrophages from patients with cirrhosis
10. Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamine
11. HCV epitope, homologous to multiple human protein sequences, induces a regulatory T cell response in infected patients
12. Absent in melanoma 2 triggers a heightened inflammasome response in ascitic fluid macrophages of patients with cirrhosis
13. THU-341 - Study of epigenetic control of LSECtin in hepatic antigen presenting cells during experimental cirrhosis
14. Role of interleukin 10 in norfloxacin prevention of luminal free endotoxin translocation in mice with cirrhosis
15. Impaired liver regeneration in Ldlr−/− mice is associated with an altered hepatic profile of cytokines, growth factors, and lipids
16. Hepatitis Outreach Network: A practical strategy for hepatitis screening with linkage to care in foreign-born communities
17. C-Reactive protein predicts short-term mortality in patients with cirrhosis
18. Evidence of neutrophil functional defect despite inflammation in stable cirrhosis
19. Presence of bacterial-DNA in cirrhosis identifies a subgroup of patients with marked inflammatory response not related to endotoxin
20. Bacterial translocation is downregulated by anti-TNF-α monoclonal antibody administration in rats with cirrhosis and ascites
21. SAT-345 - Bacterial translocation has an early onset in cirrhosis and induces a selective inflammatory response
22. Erratum to: “Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH (J Hepatol 2020; 73: 17–25)
23. Lack of histological steatohepatitis features in advanced fibrosis could impact in screening failure rate: a comparison with FDA clinical criteria
24. Risk factors associated to NAFLD-related advanced fibrosis in patients with normal ALT levels
25. THU086 - Mortality prediction in non-alcoholic fatty liver disease using SteatoSITE: an integrated gene-to-patient data commons for high-definition non-alcoholic fatty liver disease research
26. THU194 - Fate of HDV-specific CD8+ T cells during bulevirtide monotherapy in patients with chronic hepatitis delta
27. Bifidobacterium pseudocatenulatum CECT7765 induces an M2 anti-inflammatory transition in macrophages from patients with cirrhosis
28. FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis
29. PS-200-The combination of HEPAmet fibrosis score and transient elastography shows a high diagnostic accuracy in predicting advanced fibrosis in NAFLD
30. PS-148-Liver sinusoidal endothelial cells significantly cooperate in the phagocytic immune activities and activation of the adaptive T cell response in a model of experimental cirrhosis by CCl4
31. SAT-058-In hepatic cirrhosis, the systemic levels of short chain fatty acids inversely correlate with the level of endotoxemia, and are negatively associated with an increased inflammatory response, impaired liver function and a higher HVPG
32. PS-200-The combination of HEPAmet fibrosis score and transient elastography shows a high diagnostic accuracy in predicting advanced fibrosis in NAFLD
33. Role of interleukin 10 in norfloxacin prevention of luminal free endotoxin translocation in mice with cirrhosis
34. Metabolically unhealthy status impacts on the risk of significant liver injury in biopsy-proven NAFLD patients beyond obesity
35. Hepamet Score: a new non-invasive method for NAFLD-related fibrosis screening in clinical practice
36. LSECtin and CD206 participate in the regulation of the hepatic inflammatory response to E coli in a model of cirrhosis
37. PS-148-Liver sinusoidal endothelial cells significantly cooperate in the phagocytic immune activities and activation of the adaptive T cell response in a model of experimental cirrhosis by CCl4
38. SAT-058-In hepatic cirrhosis, the systemic levels of short chain fatty acids inversely correlate with the level of endotoxemia, and are negatively associated with an increased inflammatory response, impaired liver function and a higher HVPG
39. LSECtin and CD206 participate in the regulation of the hepatic inflammatory response to E coli in a model of cirrhosis
40. Polymorphisms in toll-like receptors identify a defective oxidative response and a reduction in the regulatory T cell population in patients with cirrhosis and non-infected ascites
41. Clinical Outcomes in biopsy-proven NAFLD patients from the HEPAmet Spanish Registry
42. Hepamet Score: a new non-invasive method for NAFLD-related fibrosis screening in clinical practice
43. Metabolically unhealthy status impacts on the risk of significant liver injury in biopsy-proven NAFLD patients beyond obesity
44. Regulatory T cells modulate the concentration of short chain fatty acids and the Th function in response to induced bacterial traslocation episodes, and improve the integrity of the gut barrier in an experimental cirrhosis model
45. SAT325 - Changes in the hepatitis C cascade of care among individuals attending primary and community health services before and after the introduction of direct-acting antiviral treatment in Australia
46. FRI467 - T cell exhaustion dynamics are linked to clinical outcomes in hepatocellular carcinoma
47. FRI452 - Non-invasive tests of fibrosis and risk of liver-related complications: observations following successful sofosbuvir-based treatment in patients with HCV cirrhosis
48. FRI133 - Durability of treatment response after 1 year of therapy with seladelpar in patients with primary biliary cholangitis (PBC): final results of an international phase 2 study
49. THU024 - Risk factors associated to NAFLD-related advanced fibrosis in patients with normal ALT levels
50. THU023 - Lack of histological steatohepatitis features in advanced fibrosis could impact in screening failure rate: a comparison with FDA clinical criteria
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.